Opportunities and challenges in vaccine delivery

被引:14
作者
Carstens, Myrra G. [1 ]
机构
[1] Leiden Univ, Fac Sci, Div Drug Delivery Technol, LACDR, NL-2333 CC Leiden, Netherlands
关键词
Vaccine delivery; EUFEPS workshop report; Adjuvant technology; Antigen formulation; Needle-free delivery; Particulate delivery systems; MICRONEEDLE ARRAYS; DNA VACCINATION; RATIONAL DESIGN; HUMAN SKIN; ADJUVANT; MICROPARTICLES; IMMUNOGENICITY; PROTECTION; LECTINS; ANTIGEN;
D O I
10.1016/j.ejps.2008.11.004
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This report is a distillation of the workshop 'Opportunities and Challenges in Vaccine Delivery', organised by EUFEPS/FIP and co-sponsored by AAPS and CRS, in Archamps, France, September 2008. The aim of this workshop was to bridge knowledge gaps between the different disciplines involved in the delivery of vaccines. Here, key challenges include target identification, mapping the needs and target population, the development and harmonisation of predictive read-out systems and surrogate markers for protection, and improving antigen immunogenicity, delivery and stability. The workshop underlined the need and possibilities of a multidisciplinary approach to meet these challenges. This involves increasing our understanding of immunological mechanisms, the development of advanced delivery systems and adjuvant technologies, and insight into the regulatory guidelines and target population. Based upon this knowledge, future vaccinology can increasingly focus on rational design of antigens, adjuvants and delivery systems, which will lead to new and improved vaccines. (c) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:605 / 608
页数:4
相关论文
共 34 条
  • [1] Cationic Liposomes Formulated with Synthetic Mycobacterial Cordfactor (CAF01): A Versatile Adjuvant for Vaccines with Different Immunological Requirements
    Agger, Else Marie
    Rosenkrands, Ida
    Hansen, Jon
    Brahimi, Karima
    Vandahl, Brian S.
    Aagaard, Claus
    Werninghaus, Kerstin
    Kirschning, Carsten
    Lang, Roland
    Christensen, Dennis
    Theisen, Michael
    Follmann, Frank
    Andersen, Peter
    [J]. PLOS ONE, 2008, 3 (09):
  • [2] N-Trimethyl chitosan (TMC) nanoparticles loaded with influenza subunit antigen for intranasal vaccination:: Biological properties and immunogenicity in a mouse model
    Amidi, Maryam
    Romeijn, Stefan G.
    Verhoef, J. Coos
    Junginger, Hans E.
    Bungener, Laura
    Huckriede, Anke
    Crommelin, Daan J. A.
    Jiskoot, Wim
    [J]. VACCINE, 2007, 25 (01) : 144 - 153
  • [3] Cross-protection by MF59™-adjuvanted influenza vaccine:: Neutralizing and haemagglutination-inhibiting antibody activity against A(H3N2) drifted influenza viruses
    Ansaldi, Filippo
    Bacilieri, Sabrina
    Durando, Paolo
    Sticchi, Laura
    Valle, Laura
    Montomoli, Ernanuele
    Icardi, Giancarlo
    Gasparini, Roberto
    Crovari, Pietro
    [J]. VACCINE, 2008, 26 (12) : 1525 - 1529
  • [4] Opinion - Therapeutic vaccination for chronic diseases: a new class of drugs in sight
    Bachmann, MF
    Dyer, MR
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2004, 3 (01) : 81 - 88A
  • [5] In vivo assessment of safety of microneedle arrays in human skin
    Bal, Suzanne M.
    Caussin, Julia
    Pavel, Stan
    Bouwstra, Joke A.
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2008, 35 (03) : 193 - 202
  • [6] Pulmonary DNA vaccination: Concepts, possibilities and perspectives
    Bivas-Benita, M
    Ottenhoff, THM
    Junginger, HE
    Borchard, G
    [J]. JOURNAL OF CONTROLLED RELEASE, 2005, 107 (01) : 1 - 29
  • [7] Pulmonary delivery of chitosan-DNA nanoparticles enhances the immunogenicity of a DNA vaccine encoding HLA-A*0201-restricted T-cell epitopes of Mycobacterium tuberculosis
    Bivas-Benita, M
    van Meijgaarden, KE
    Franken, KLMC
    Junginger, HE
    Borchard, G
    Ottenhoff, THM
    Geluk, A
    [J]. VACCINE, 2004, 22 (13-14) : 1609 - 1615
  • [8] Need for new vaccine formulations and potential of particulate antigen and DNA delivery systems
    Friede, M
    Aguado, MT
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2005, 57 (03) : 325 - 331
  • [9] Pre-clinical and clinical investigation of the safety of a novel adjuvant for intranasal immunization
    Glueck, R
    [J]. VACCINE, 2001, 20 : S42 - S44
  • [10] A protective allergy vaccine based on CpG- and protamine-containing PLGA microparticles
    Gomez, Julia M. Martinez
    Fischer, Stefan
    Csaba, Noemi
    Kuendig, Thomas M.
    Merkle, Hans P.
    Gander, Bruno
    Johansen, Pal
    [J]. PHARMACEUTICAL RESEARCH, 2007, 24 (10) : 1927 - 1935